Intellectual Property Contracts & Agreements in the Unassigned Industry

2,730 Contracts & Agreements

Browse by Company

Recent Contracts

Amendment to Amended and Restated Distribution License and Marketing Services Agreement, dated September 30, 2024, by and between the 5&2 Studios, Inc. and Come and See... (Chosen, Inc., Filed With SEC on December 6, 2024)
Brand License Agreement, dated as of December 2, 2024, by and between TechTarget, Inc. (formerly known as Toro CombineCo, Inc.) and Informa Group Limited (Toro CombineCo, Inc., Filed With SEC on December 3, 2024)
Amendment No. 1 to Second Amended and Restated Supply and License Agreement, dated March 5, 2024, between 4C Medical Technologies, Inc. and Anteris Technologies Corporation (Anteris Technologies Global Corp., Filed With SEC on November 22, 2024)
Second Amended and Restated Supply and License Agreement, dated June 1, 2018, between 4C Medical Technologies, Inc. and Admedus Corporation (Anteris Technologies Global Corp., Filed With SEC on November 22, 2024)
License Agreement, dated October 11, 2019, among Admedus Ltd, Admedus Regen Pty Ltd, Admedus Biomanufacturing Pty Ltd and LeMaitre Vascular, Inc (Anteris Technologies Global Corp., Filed With SEC on November 22, 2024)
Amendment to License Agreement with Monarch Media (Blue Line Holdings, Inc., Filed With SEC on November 19, 2024)
License Agreement with Monarch Media, LLC (Blue Line Holdings, Inc., Filed With SEC on November 19, 2024)
Fourth Amendment to Exclusive License Agreement (Sensitization of Solid Tumors), dated November 13, 2024, by and between Enviro Therapeutics Inc. and Cedars-Sinai Medical Center (Kairos Pharma, LTD., Filed With SEC on November 14, 2024)
Third Amendment to Exclusive License Agreement (RelA of NF-kB), dated November 13, 2024, by and between Kairos Pharma, Ltd. and Cedars-Sinai Medical Center (Kairos Pharma, LTD., Filed With SEC on November 14, 2024)
Third Amendment to Exclusive License Agreement (Fibrosis), dated November 13, 2024, by and between Kairos Pharma, Ltd. and Cedars-Sinai Medical Center (Kairos Pharma, LTD., Filed With SEC on November 14, 2024)
Fourth Amendment to Exclusive License Agreement (Depletion of DNA), dated November 13, 2024, by and between Kairos Pharma, Ltd. and Cedars-Sinai Medical Center and Enviro... (Kairos Pharma, LTD., Filed With SEC on November 14, 2024)
Third Amendment to Exclusive License Agreement (Cancer Autoimmune), dated November 13, 2024, by and between Kairos Pharma, Ltd. and Cedars-Sinai Medical Center (Kairos Pharma, LTD., Filed With SEC on November 14, 2024)
Fifth Amendment to Data License Agreement dated September 26, 2024 (SURF AIR MOBILITY INC., Filed With SEC on November 14, 2024)
Amendment No. 4 to License Agreement, dated September 27, 2024, by and between the Broad Institute, Inc. and the Registrant (Prime Medicine, Inc., Filed With SEC on November 12, 2024)
Amendment to License Agreement with Monarch Media (Blue Line Holdings, Inc., Filed With SEC on October 30, 2024)
License Agreement with Monarch Media, LLC (Blue Line Holdings, Inc., Filed With SEC on October 30, 2024)
License Agreement with Monarch Media, LLC (Blue Line Holdings, Inc., Filed With SEC on September 24, 2024)
Second Amendment to Patent License Agreement by and between CAMP4 Therapeutics Corporation and the Whitehead Institute for Biomedical Research, dated as of November 7, 2023 (Camp4 Therapeutics Corp, Filed With SEC on September 20, 2024)
First Amendment to Patent License Agreement by and between CAMP4 Therapeutics Corporation and the Whitehead Institute for Biomedical Research, dated as of December 14, 2021 (Camp4 Therapeutics Corp, Filed With SEC on September 20, 2024)
Patent License Agreement by and between CAMP4 Therapeutics Corporation and the Whitehead Institute for Biomedical Research, dated as of October 23, 2019 (Camp4 Therapeutics Corp, Filed With SEC on September 20, 2024)
Curacao Gaming License issued to Interstellar Entertainment N.V, dated July 16, 2024 (High Roller Technologies, Inc., Filed With SEC on September 19, 2024)
Amendment No. 1 to the License Agreement effective the 15th Day of June 2015 by and between the Board of Trustees of the Leland Stanford Junior University and CeriBell, Inc.,... (Ceribell, Inc., Filed With SEC on September 19, 2024)
License Agreement, by and between the registrant and NWALP TPOP Property Owner LLC, dated as of September 13, 2022, as amended (Upstream Bio, Inc., Filed With SEC on September 18, 2024)
License Agreement, by and between the registrant and Lonza Sales AG, dated October 21, 2021, as amended (Upstream Bio, Inc., Filed With SEC on September 18, 2024)
Exclusive License Agreement, by and between the registrant and Maruho Co., Ltd., dated October 14, 2021, as amended (Upstream Bio, Inc., Filed With SEC on September 18, 2024)
Exclusive License Agreement by and between the Registrant and Amgen Inc. dated April 5, 2021, as amended (BioAge Labs, Inc., Filed With SEC on September 3, 2024)
Himalaya Technologies, Inc. InsureTEK Tech License and Partnership Agreement 08/12/2024 (HOMELAND RESOURCES LTD., Filed With SEC on September 3, 2024)
Amendment No. 3 to the License Agreement effective the 15th Day of June 2015, by and between the Board of Trustees of the Leland Stanford Junior University and CeriBell, Inc.,... (Ceribell, Inc., Filed With SEC on August 26, 2024)
Amendment No. 2 to the License Agreement effective the 15th Day of June 2015 and amended the 14th Day of September 2015, by and between the Board of Trustees of the Leland... (Ceribell, Inc., Filed With SEC on August 26, 2024)
Amendment No. 1 to the License Agreement effective the 15th Day of June 2015 by and between the Board of Trustees of the Leland Stanford Junior University and CeriBell, Inc.,... (Ceribell, Inc., Filed With SEC on August 26, 2024)
Exclusive License Agreement, dated as of June 10, 2020, between Indiana University Research and Technology Corporation and MBX Biosciences, Inc., as amended (MBX Biosciences, Inc., Filed With SEC on August 23, 2024)
License Agreement by and between the Registrant and Bristol-Myers Squibb Company, dated as of August 30, 2023 (Zenas BioPharma, Inc., Filed With SEC on August 22, 2024)
Second Amendment to License Agreement by and between Zenas BioPharma, Inc. and Xencor, Inc., dated May 27, 2021 (Zenas BioPharma, Inc., Filed With SEC on August 22, 2024)
First Amendment to License Agreement by and between Zenas BioPharma (Cayman) Limited and Xencor, Inc., dated May 27, 2021 (Zenas BioPharma, Inc., Filed With SEC on August 22, 2024)
License Agreement by and between Zenas BioPharma (Cayman) Limited and Xencor, Inc., dated May 27, 2021 (Zenas BioPharma, Inc., Filed With SEC on August 22, 2024)
First Amendment to License Agreement by and between Zenas BioPharma, Inc. and Xencor, Inc., dated June 24, 2024 (Zenas BioPharma, Inc., Filed With SEC on August 22, 2024)
License Agreement by and between Zenas BioPharma (Cayman) Limited and Xencor, Inc., dated September 23, 2020 (Zenas BioPharma, Inc., Filed With SEC on August 22, 2024)
Parking License Agreement by and between Toppoint Inc and 87 Doremus Ave LLC , dated June 1, 2024 (Toppoint Holdings Inc., Filed With SEC on August 12, 2024)
License Agreement by and between Axens North America, Inc. and New Rise Renewables Reno, LLC (Focus Impact BH3 NewCo, Inc., Filed With SEC on July 31, 2024)
License Agreement, by and between Supplier and the Registrant, dated November 10, 2023 (zSpace, Inc., Filed With SEC on July 22, 2024)